539680 — GANGA PHARMACEUTICALS Cashflow Statement
0.000.00%
- IN₹65.34m
- IN₹76.19m
- IN₹27.36m
- 10
- 22
- 39
- 10
Annual cashflow statement for GANGA PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | ARS | ARS |
Standards: | IAS | IAS |
Status: | Final | Final |
Net Income/Starting Line | 0.531 | 0.633 |
Depreciation | ||
Non-Cash Items | -1.11 | -0.585 |
Other Non-Cash Items | ||
Changes in Working Capital | -0.378 | -13.2 |
Change in Accounts Receivable | ||
Change in Inventories | ||
Change in Other Assets | ||
Change in Accounts Payable | ||
Change in Other Liabilities | ||
Other Operating Cash Flow | ||
Cash from Operating Activities | -0.399 | -12.6 |
Capital Expenditures | -0.148 | -0.224 |
Purchase of Fixed Assets | ||
Other Investing Cash Flow Items | 5.07 | 1.52 |
Change in Net Investments | ||
Other Investing Cash Flow | ||
Cash from Investing Activities | 4.92 | 1.3 |
Financing Cash Flow Items | -1.87 | -1.81 |
Other Financing Cash Flow | ||
Net Issuance / Retirement of Stock | ||
Net Issuance / Retirement of Debt | ||
Cash from Financing Activities | -4.44 | 11.4 |
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | 0.086 | 0.008 |